These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 9593588)

  • 1. Neuropeptide FF, pain and analgesia.
    Roumy M; Zajac JM
    Eur J Pharmacol; 1998 Mar; 345(1):1-11. PubMed ID: 9593588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide FF receptors control morphine-induced analgesia in the parafascicular nucleus and the dorsal raphe nucleus.
    Dupouy V; Zajac JM
    Eur J Pharmacol; 1997 Jul; 330(2-3):129-37. PubMed ID: 9253945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of neuropeptide FF analogs on morphine analgesia in the nucleus raphe dorsalis.
    Dupouy V; Zajac JM
    Regul Pept; 1995 Nov; 59(3):349-56. PubMed ID: 8577940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical, cellular and pharmacological activities of a human neuropeptide FF-related peptide.
    Gelot A; Mazarguil H; Dupuy P; Francés B; Gouardères C; Roumy M; Zajac JM
    Eur J Pharmacol; 1998 Aug; 354(2-3):167-72. PubMed ID: 9754917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory influences of mammalian FMRFamide (Phe-Met-Arg-Phe-amide)-related peptides on nociception and morphine- and stress-induced analgesia in mice.
    Kavaliers M
    Neurosci Lett; 1990 Jul; 115(2-3):307-12. PubMed ID: 2234508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal DN-9, a Peptidic Multifunctional Opioid/Neuropeptide FF Agonist Produced Potent Nontolerance Forming Analgesia With Limited Side Effects.
    Wang Z; Xu B; Jiang C; Zhang T; Zhang M; Li N; Zhang Q; Xu K; Chen D; Xiao J; Fang Q
    J Pain; 2020; 21(3-4):477-493. PubMed ID: 31521796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical distribution and partial characterization of FLFQPQRFamidelike peptides in the central nervous system of rats.
    Kivipelto L; Majane EA; Yang HY; Panula P
    J Comp Neurol; 1989 Aug; 286(2):269-87. PubMed ID: 2794121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense oligonucleotides to human SQA-neuropeptide FF decrease morphine tolerance and dependence in mice.
    Gelot A; Francés B; Gicquel S; Zajac JM
    Eur J Pharmacol; 1998 Oct; 358(3):203-6. PubMed ID: 9822885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of adenosine in the spinal antinociceptive and morphine modulatory actions of neuropeptide FF analogs.
    Gouardères C; Sutak M; Zajac JM; Jhamandas K
    Eur J Pharmacol; 2000 Oct; 406(3):391-401. PubMed ID: 11040346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
    Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
    Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-opioid efficacy of neuropeptide FF in morphine-tolerant mice.
    Gelot A; Francés B; Roussin A; Latapie JP; Zajac JM
    Brain Res; 1998 Oct; 808(2):166-73. PubMed ID: 9767158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Origin and distribution of neuropeptide-FF-like immunoreactivity in the spinal cord of rats.
    Kivipelto L; Panula P
    J Comp Neurol; 1991 May; 307(1):107-19. PubMed ID: 1856315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low affinity of FMRFamide and four FaRPs (FMRFamide-related peptides), including the mammalian-derived FaRPs F-8-Famide (NPFF) and A-18-Famide, for opioid mu, delta, kappa 1, kappa 2a, or kappa 2b receptors.
    Raffa RB; Kim A; Rice KC; de Costa BR; Codd EE; Rothman RB
    Peptides; 1994; 15(3):401-4. PubMed ID: 7937312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous opiates and behavior: 2012.
    Bodnar RJ
    Peptides; 2013 Dec; 50():55-95. PubMed ID: 24126281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity of neuropeptide FF analogs to opioid receptors in the rat spinal cord.
    Gouardères C; Tafani JA; Zajac JM
    Peptides; 1998; 19(4):727-30. PubMed ID: 9622028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mammalian FMRF-NH2-related peptides and IgG from antiserum against them on aggression and defeat-induced analgesia in mice.
    Kavaliers M; Yang HY
    Peptides; 1991; 12(2):235-9. PubMed ID: 2067975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of pharmacological pro- and anti-opioid effects by neuropeptide FF analogs.
    Quelven I; Roussin A; Burlet-Schiltz O; Gouardères C; Tafani JA; Mazarguil H; Zajac JM
    Eur J Pharmacol; 2002 Aug; 449(1-2):91-8. PubMed ID: 12163111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of neuropeptide FF-related peptides in rodent spinal cord.
    Bonnard E; Burlet-Schiltz O; Francés B; Mazarguil H; Monsarrat B; Zajac JM; Roussin A
    Peptides; 2001 Jul; 22(7):1085-92. PubMed ID: 11445238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.
    Gouardères C; Jhamandas K; Sutak M; Zajac JM
    Br J Pharmacol; 1996 Feb; 117(3):493-501. PubMed ID: 8821539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic intracerebroventricular infusion of the antiopioid peptide, Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 (NPFF), downregulates mu opioid binding sites in rat brain.
    Rothman RB; Brady LS; Xu H; Long JB
    Peptides; 1993; 14(6):1271-7. PubMed ID: 8134310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.